AntiVEGF therapy vs Ozurdex for the treatment of Diabetic Macular Edema

Authors

Wendell Jones

Discipline

Ophthalmology

Funder

National Institutes of Health (NIH)

Field

Medical, Health, & Life Sciences

Organization

Washington University in St. Louis; Working Group on NIH DMSP Guidance

Location

United States

Description

This DMP outlines the data management process of a human study evaluating the use of a novel drug, Ozurdex on treating Diabetic Macular Edema.

Date Last Modified

2023

Keywords

diabetes

clinical trial

novel treatment

Link